8-K
Intelligent Bio Solutions Inc. Adopts Second Amended and Restated Bylaws and Furnishes Investor Presentation
8-K
Intelligent Bio Solutions Inc. Updates Common Stock Share Count to 3,316,803 Following Warrant Exercises and Stock Issuance
8-K
Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System
8-K
Intelligent Bio Solutions Announces $5 Million Private Placement and Potential $10 Million Tranche
8-K
Intelligent Bio Solutions Reports Over 98% Accuracy in Clinical Study for Fingerprinting Drug Screening System
8-K
Intelligent Bio Solutions Inc. Releases Investor Presentation
